No Matches Found
No Matches Found
No Matches Found
Shanxi C&Y Pharmaceutical Group Co., Ltd.
Shanxi C&Y Pharmaceutical Hits Day High with 10.99% Surge
Shanxi C&Y Pharmaceutical Group Co., Ltd. saw a notable stock increase today, contrasting with the broader market's modest gains. However, the company's longer-term performance shows a decline over the past month and year, alongside challenges in profitability and a relatively high price-to-book ratio.
Shanxi C&Y Pharmaceutical Hits Day Low at CNY 10.41 Amid Price Pressure
Shanxi C&Y Pharmaceutical Group Co., Ltd. faced a notable decline in stock value, contrasting with broader market trends. The company has struggled with low profitability and a high Debt to Equity ratio, while also experiencing a contraction in net sales over the past five years, raising concerns about its growth potential.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
